These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38762658)
1. Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid. Khan H; Jan F; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Ullah S; Al-Harrasi A; Khan M; Ali S Sci Rep; 2024 May; 14(1):11410. PubMed ID: 38762658 [TBL] [Abstract][Full Text] [Related]
2. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition. Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079 [TBL] [Abstract][Full Text] [Related]
3. Isatin based Schiff bases as inhibitors of α-glucosidase: Synthesis, characterization, in vitro evaluation and molecular docking studies. Rahim F; Malik F; Ullah H; Wadood A; Khan F; Javid MT; Taha M; Rehman W; Ur Rehman A; Khan KM Bioorg Chem; 2015 Jun; 60():42-8. PubMed ID: 25955493 [TBL] [Abstract][Full Text] [Related]
4. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach. Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors. Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological activities, and molecular docking studies of 2-mercaptobenzimidazole based derivatives. Ali M; Ali S; Khan M; Rashid U; Ahmad M; Khan A; Al-Harrasi A; Ullah F; Latif A Bioorg Chem; 2018 Oct; 80():472-479. PubMed ID: 29990895 [TBL] [Abstract][Full Text] [Related]
7. Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies. Zawawi NK; Taha M; Ahmat N; Wadood A; Ismail NH; Rahim F; Azam SS; Abdullah N Bioorg Chem; 2016 Feb; 64():29-36. PubMed ID: 26637946 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies. Imran S; Taha M; Ismail NH; Kashif SM; Rahim F; Jamil W; Hariono M; Yusuf M; Wahab H Eur J Med Chem; 2015 Nov; 105():156-70. PubMed ID: 26491979 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives. Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study. Rahim F; Zaman K; Taha M; Ullah H; Ghufran M; Wadood A; Rehman W; Uddin N; Shah SAA; Sajid M; Nawaz F; Khan KM Bioorg Chem; 2020 Jan; 94():103394. PubMed ID: 31699396 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro α-glucosidase inhibitory potential and molecular docking study of thiadiazole analogs. Javid MT; Rahim F; Taha M; Rehman HU; Nawaz M; Wadood A; Imran S; Uddin I; Mosaddik A; Khan KM Bioorg Chem; 2018 Aug; 78():201-209. PubMed ID: 29597114 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking and DFT analysis of novel bis-Schiff base derivatives with thiobarbituric acid for α-glucosidase inhibition assessment. Gul S; Jan F; Alam A; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Khan M; Bo L Sci Rep; 2024 Feb; 14(1):3419. PubMed ID: 38341468 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of indole-based-thiadiazole derivatives as a potent inhibitor of α-glucosidase enzyme along with in silico study. Alomari M; Taha M; Rahim F; Selvaraj M; Iqbal N; Chigurupati S; Hussain S; Uddin N; Almandil NB; Nawaz M; Khalid Farooq R; Khan KM Bioorg Chem; 2021 Mar; 108():104638. PubMed ID: 33508679 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors. Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies. Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, Molecular Modeling and Biological Evaluation of 5-arylidene-N,N-diethylthiobarbiturates as Potential α-glucosidase Inhibitors. Khan M; Khan S; Ul Mulk A; Ur Rahman A; Wadood A; Shams S; Ashraf M; Rahman J; Khan I; Hameed A; Hussain Z; Khan A; Zaman K; Khan KM; Perveen S Med Chem; 2019; 15(2):175-185. PubMed ID: 30207240 [TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies. Peytam F; Adib M; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Mahdavi M; Moghadamnia AA; Rastegar H; Larijani B Mol Divers; 2020 Feb; 24(1):69-80. PubMed ID: 30825061 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of 3-hydroxy-2-naphthohydrazide-based hydrazones and their implications in diabetic management via in vitro and in silico approaches. Tasleem M; Ullah S; Halim SA; Urooj I; Ahmed N; Munir R; Khan A; El-Kott AF; Taslimi P; Negm S; Al-Harrasi A; Shafiq Z Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300544. PubMed ID: 38013251 [TBL] [Abstract][Full Text] [Related]
20. Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus. Daoud S; Thiab S; Jazzazi TMA; Al-Shboul TMA; Ullah S Acta Pharm; 2022 Sep; 72(3):449-458. PubMed ID: 36651543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]